Latest stock price today and the US's most active stock market forums. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. CHESTERBROOK, Pa., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (“CNS”) disorders, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. Today's Change … Why Trevena's Stock Is Moving Today. Trevena (TRVN) will provide updates on its newly launched drug and other pipeline products when it releases its third-quarter 2020 results. Taking a more long-term approach, TRVN poste CHESTERBROOK, Pa., June 28, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced it has been added to the small-cap Russell 2000® Index, the broad-market Russell 3000® Index, and the Russell Microcap® … 52 Week Range ... Latest News. Get the latest Trevena Inc (6T4) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Trevena Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. CHESTERBROOK, Pa. (AP) _ Trevena Inc. (TRVN) on Thursday reported a loss of $9.8 million in its first quarter. The stock remained 10.31% volatile for the week and 10.34% for the month. Trevena (TRVN) Stock Hit with a Downgrade; Shares Tumble Over 10%. The current price level -56.25% lower than the highest price of $3.68 marked by the stock while trading over the past 52-weeks, whereas it is 12.59% higher than the lowest price of $1.43 the company dropped to over past 52-weeks. Trevena Inc. (TRVN): The long term indicators on the stock say Sell today. Investors need to pay close attention to Trevena (TRVN) stock based on the movements in the options market lately. Trevena Inc. (TRVN) saw downtrend of 0.00% in the recent trading with $1.61 being its most recent. The stock … Despite the recent pullback, Trevena (TRVN) stock has had an excellent 2020 with shares rocketing 182% year-to-date. TRVN Quick Quote TRVN Positive Net Change. Trevena, Inc. Common Stock (TRVN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. ... Company News for June 3, 2020. Tickers TRVN. Trevena Announces Presentations of OLINVYK® Health Economic Models at ISPOR 2021. Why Trevena Stock Is Plunging Today (MotleyFool) 10.08.20: ... Trevena News: auf dieser Seite finden Sie alle Trevena News und Nachrichten zur Trevena … It could become the mother of all technological revolutions. Get today's Trevena Inc stock news. Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system disorders, today announced that it will release its financial results for the first quarter ended March 31, 2021, prior to the market open on Thursday, May 6, 2021. Nhwa in-licensed China rights to the painkiller from Trevena, a ... From ChinaBio® Today. A high-level overview of Trevena, Inc. (TRVN) stock. Trevena, Inc. (TRVN) is working its way for to the bottom in the market today. Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System conditions. View detailed financial information, real-time news, videos, quotes and analysis on Trevena, Inc. (NASDAQ:TRVN). Trevena, Inc. price-eps-surprise | Trevena, Inc. Quote. Free … Get the free 2021 Dogs of the Dow Checklist. Trevena, Inc. price-eps-surprise | Trevena, Inc. Quote. CHESTERBROOK, Pa. (AP) _ Trevena Inc. (TRVN) on Thursday reported a loss of $9.8 million in its first quarter. Trevena (NASDAQ:TRVN) shares slide over 10% during premarket trading after the company proposed a potential reverse stock split cutting the … Trevena, Inc. (NASDAQ:TRVN) today announced the first scientific presentation of positive results from two Phase 3 pivotal efficacy studies of OLINVO™ (oliceridine injection), an investigational, next-generation intravenous (IV) opioid analgesic in development for the management of moderate-to-severe acute pain in the hospital and similar settings. More Trevena News. Trevena… At the very opening of the session, the stock price was $1.65 and reached a high price of $1.805, prior to closing the session it reached the value of $1.70. All News News Headlines Press Releases. Find real-time TRVN - Trevena Inc stock quotes, company profile, news and forecasts from CNN Business. Trevena Inc. ( TRVN) had a rough trading day for Monday January 11 as shares tumbled 9.17%, or a loss of $-0.22 per share, to … TRVN stock fluctuated between $2.01 and $2.18 on the day. The company’s stock price has collected 2.62% of gains in the last five trading sessions. >> 7 Top Picks for the Jun. With such positive news surrounding Trevena, it’s no surprise that the stock is making a run for the top in the market today. Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Carrie Bourdow, President and Chief Executive. Home / Stock Picks / Stock Market Today / 3 Stocks to Watch on Wednesday: Moneygram International Inc (MGI), Trevena Inc (TRVN) and Tetraphase Pharmaceuticals Inc (TTPH) Trevena is a biopharmaceutical company focused on the development of novel medicines for patients with central nervous system conditions. TRVN Stock Message Board for Investors. Trevena's stock traded up 15.46% at $1.81 per share at the time of publication on Friday. TRVN 1.62 0.01 (0.62%). News. Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Carrie Bourdow, President and Chief Executive. Trevena Inc. stock has also loss -27.48% of its value over the past 7 days. Jun. The stock's open price was 1.78. Trevena Added to Russell 2000®, Russell 3000®, and Russell Microcap® Indexes. Get the latest Trevena, Inc. TRVN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Trevena (TRVN) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes. Over the past six months meanwhile, it has gained 202.59% and gained 169.95% year-on date. Trevena Inc () Stock Market info Recommendations: Buy or sell Trevena stock? Image source: Getty Images. Shares of Trevena Inc. ( TRVN) are gathering steam in the run-up to a regulatory catalyst, which is only just days away. Press Release reported on 06/16/21 that Thinking about buying stock in … Trevena Inc stock news. Shares in Trevena Inc are currently trading at $1.8 and the price has moved by 37.4% over the past 365 days. Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced two poster. The stock fluctuated between $1.93 and $2.00 throughout the day. Why Trevena Stock Is Plunging Today. As it relates to biotechnology stocks, there are several factors that have the potential to lead to price movement in the market. In that particular session, Stock kicked-off at the price of $1.75 while reaching the peak value of $1.76 and lowest value recorded on the day was $1.70.